Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion
- Byndloss, Mariana X;
- Olsan, Erin E;
- Rivera-Chávez, Fabian;
- Tiffany, Connor R;
- Cevallos, Stephanie A;
- Lokken, Kristen L;
- Torres, Teresa P;
- Byndloss, Austin J;
- Faber, Franziska;
- Gao, Yandong;
- Litvak, Yael;
- Lopez, Christopher A;
- Xu, Gege;
- Napoli, Eleonora;
- Giulivi, Cecilia;
- Tsolis, Renée M;
- Revzin, Alexander;
- Lebrilla, Carlito B;
- Bäumler, Andreas J
- et al.
Published Web Location
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642957/Abstract
Perturbation of the gut-associated microbial community may underlie many human illnesses, but the mechanisms that maintain homeostasis are poorly understood. We found that the depletion of butyrate-producing microbes by antibiotic treatment reduced epithelial signaling through the intracellular butyrate sensor peroxisome proliferator-activated receptor γ (PPAR-γ). Nitrate levels increased in the colonic lumen because epithelial expression of Nos2, the gene encoding inducible nitric oxide synthase, was elevated in the absence of PPAR-γ signaling. Microbiota-induced PPAR-γ signaling also limits the luminal bioavailability of oxygen by driving the energy metabolism of colonic epithelial cells (colonocytes) toward β-oxidation. Therefore, microbiota-activated PPAR-γ signaling is a homeostatic pathway that prevents a dysbiotic expansion of potentially pathogenic Escherichia and Salmonella by reducing the bioavailability of respiratory electron acceptors to Enterobacteriaceae in the lumen of the colon.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.